Cargando…
Evaluation of a novel type of imaging probe based on a recombinant bivalent mini-antibody construct for detection of CD44v6-expressing squamous cell carcinoma
We have developed the CD44v6-targeting human bivalent antibody fragment AbD19384, an engineered recombinant human bivalent Fab antibody formed via dimerization of dHLX (synthetic double helix loop helix motif) domains, for potential use in antibody-based molecular imaging of squamous cell carcinoma...
Autores principales: | HAYLOCK, ANNA-KARIN, SPIEGELBERG, DIANA, MORTENSEN, ANJA C., SELVARAJU, RAM K., NILVEBRANT, JOHAN, ERIKSSON, OLOF, TOLMACHEV, VLADIMIR, NESTOR, MARIKA V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725455/ https://www.ncbi.nlm.nih.gov/pubmed/26676731 http://dx.doi.org/10.3892/ijo.2015.3290 |
Ejemplares similares
-
Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model
por: Spiegelberg, Diana, et al.
Publicado: (2015) -
Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy
por: Mortensen, Anja C., et al.
Publicado: (2018) -
In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study
por: Haylock, Anna-Karin, et al.
Publicado: (2014) -
Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers
por: Haylock, Anna-Karin, et al.
Publicado: (2017) -
CD44v6-Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody-Based Approaches
por: Spiegelberg, Diana, et al.
Publicado: (2017)